Georgette Review PMHNP Exam Preparation Newest With Complete Questions
And Correct Detailed Answers| Brand New Version!
Question 1
An adolescent patient presents to the clinic and makes a claim of physical abuse by a family
member. The claim is made while both parents are present in the room. What is the most
appropriate immediate action for the Psychiatric-Mental Health Nurse Practitioner (PMHNP) to
take?
A) Document the claim and ask the parents to explain the situation.
B) Call Child Protective Services (CPS) immediately while the parents are in the room.
C) Interview the adolescent alone without the parents present and then call CPS.
D) Advise the adolescent that making false claims has legal consequences.
E) Referral to a family therapist before making any formal reports.
Correct Answer: C) interview the teen w/o the parents; call CPS
Rationale: Safety and objective assessment are the priorities when abuse is suspected. An
adolescent may feel intimidated or coerced if interviewed in the presence of potential
perpetrators (the parents). To obtain an accurate and untainted history, the PMHNP must
separate the teen from the parents. Once a claim of abuse is made by a minor, the PMHNP
is a mandatory reporter and must notify Child Protective Services (CPS) regardless of
personal opinion on the validity of the claim.
Question 2
Which three primary neurotransmitters are most significantly associated with the
pathophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD)?
A) Dopamine, Acetylcholine, and GABA
B) Norepinephrine, Glutamate, and Serotonin
C) Dopamine, Norepinephrine, and Serotonin (5HT)
D) Serotonin, GABA, and Oxytocin
E) Epinephrine, Histamine, and Dopamine
Correct Answer: C) DA, NE, 5HT aka serotonin
Rationale: ADHD is largely understood as a disorder of neurotransmitter dysregulation in
the brain’s executive centers. Dopamine (DA) is linked to reward, motivation, and physical
movement; Norepinephrine (NE) is critical for sustained attention and alertness; and
Serotonin (5HT) plays a role in behavioral inhibition and impulse control. Medications for
ADHD, particularly stimulants and certain non-stimulants, target these systems to improve
focus and reduce impulsivity.
Question 3
In the neurobiology of ADHD, which of the following sets of brain structures are most
commonly associated with the symptoms of the disorder?
A) Occipital lobe, Thalamus, and Amygdala
B) Frontal cortex, Basal ganglia, and Reticular Activating System
, 2
C) Cerebellum, Hippocampus, and Temporal lobe
D) Hypothalamus, Medulla oblongata, and Parietal lobe
E) Corpus callosum, Pineal gland, and Pons
Correct Answer: B) Frontal cortex, Basal ganglia, Reticular Activating System
Rationale: The Frontal Cortex manages executive functions (planning, impulse control). The
Basal Ganglia are involved in motor control and the "filtering" of information. The
Reticular Activating System (RAS) is responsible for arousal and consciousness, serving as
a gateway for sensory input. Dysfunction in the connectivity between these three regions
leads to the hallmark ADHD symptoms of inattention, hyperactivity, and impulsivity.
Question 4
A 10-year-old child is diagnosed specifically with ADHD, Inattentive Type. According to
neuroimaging studies and pathophysiological models, which specific area of the brain most
likely demonstrates abnormalities in this type?
A) Occipital cortex
B) Prefrontal cortex
C) Basal ganglia
D) Limbic system
E) Parietal lobe
Correct Answer: B) Prefrontal cortex
Rationale: The Prefrontal Cortex (PFC) is the seat of executive functioning, including the
ability to sustain attention, inhibit distracting stimuli, and organize thoughts. While the
Basal Ganglia are more linked to the hyperactive/motor components of ADHD, the
"Inattentive Type" is primarily associated with decreased activation or structural
abnormalities within the Prefrontal Cortex.
Question 5
What is the absolute priority assessment that must be completed before a PMHNP places a
pediatric or adult patient on a stimulant medication for ADHD?
A) Liver function tests (LFTs)
B) Comprehensive cardiac history and physical
C) Fasting blood glucose levels
D) Thyroid stimulating hormone (TSH) level
E) Assessing for a history of gluten intolerance
Correct Answer: B) Cardiac history
Rationale: Stimulants are sympathomimetic drugs that can increase heart rate and blood
pressure. While they are generally safe, they pose a risk to patients with undiagnosed
structural heart abnormalities, arrhythmias, or other cardiac issues. A thorough cardiac
history (including family history of sudden cardiac death) and a physical exam are
, 3
mandatory to ensure the patient can safely tolerate the stimulant's effects on the
cardiovascular system.
Question 6
A 28-year-old patient reports "excessive worry and apprehension" regarding their job, health, and
finances. They state this worry has occurred "more days than not" for the last 7 months. Which
diagnosis is most consistent with this presentation?
A) Social Anxiety Disorder
B) Panic Disorder
C) Generalized Anxiety Disorder (GAD)
D) Acute Stress Disorder
E) Obsessive-Compulsive Disorder (OCD)
Correct Answer: C) GAD
Rationale: The DSM-5 criteria for Generalized Anxiety Disorder (GAD) require excessive
anxiety and worry occurring more days than not for a period of at least 6 months about a
number of events or activities. The patient's presentation of 7 months of persistent worry
across multiple domains (job, health, finances) fits this diagnostic timeframe and pattern.
Question 7
A child presents with both ADHD and a co-occurring motor tic disorder. Which class of ADHD
medications is generally considered contraindicated or should be used with extreme caution in
this scenario?
A) Alpha-2 agonists
B) Selective Norepinephrine Reuptake Inhibitors (SNRIs)
C) Stimulants
D) Selective Serotonin Reuptake Inhibitors (SSRIs)
E) Typical Antipsychotics
Correct Answer: C) Stimulants
Rationale: Stimulants increase dopamine levels, which can potentially exacerbate motor or
vocal tics in susceptible individuals. While some recent research suggests stimulants may
not always worsen tics, traditional board exams and clinical guidelines often flag stimulants
as contraindicated or requiring extreme caution when a tic disorder is present. Non-
stimulants like Guanfacine are often preferred in these cases.
Question 8
A patient on a stimulant for ADHD reports that the medication "helped for a few hours, but then
the focus disappeared by lunch." The PMHNP determines the medication provides some but not
enough benefit. In pharmacokinetics, what is the most likely explanation?
A) The patient is not taking the medication correctly.
B) The medication has been cleared from the body too quickly.
, 4
C) The patient has developed an immediate tolerance.
D) The dose is too high, causing a paradoxical effect.
E) The patient has a co-occurring personality disorder.
Correct Answer: B) the medication has been cleared from the body
Rationale: If a patient experiences a therapeutic benefit that is short-lived or "wears off"
too quickly, it indicates that the drug’s concentration in the blood has dropped below the
therapeutic window. This is common with short-acting stimulants. The PMHNP may need
to consider a long-acting (extended-release) formulation or a second dose later in the day to
maintain coverage.
Question 9
What is the FDA-approved lower age limit for the use of Amphetamine (AMPH) based
stimulants (e.g., Adderall) in children with ADHD?
A) 1 year old
B) 3 years old
C) 5 years old
D) 6 years old
E) 12 years old
Correct Answer: B) AMPH = 3yrs
Rationale: Amphetamine-based stimulants are approved by the FDA for children as young
as 3 years old. This is an important clinical distinction compared to methylphenidate-based
stimulants, which have a higher approved age limit. However, behavioral interventions are
still recommended as first-line for preschool-aged children.
Question 10
What is the FDA-approved lower age limit for the use of Methylphenidate (MPH) based
stimulants (e.g., Ritalin) in children with ADHD?
A) 3 years old
B) 4 years old
C) 5 years old
D) 6 years old
E) 18 years old
Correct Answer: D) MPH = 6yrs
Rationale: Unlike amphetamines, which are approved starting at age 3, Methylphenidate-
based products are generally approved by the FDA for children starting at 6 years of age.
Understanding these age limits is crucial for safe and legal prescribing in pediatric
populations.
And Correct Detailed Answers| Brand New Version!
Question 1
An adolescent patient presents to the clinic and makes a claim of physical abuse by a family
member. The claim is made while both parents are present in the room. What is the most
appropriate immediate action for the Psychiatric-Mental Health Nurse Practitioner (PMHNP) to
take?
A) Document the claim and ask the parents to explain the situation.
B) Call Child Protective Services (CPS) immediately while the parents are in the room.
C) Interview the adolescent alone without the parents present and then call CPS.
D) Advise the adolescent that making false claims has legal consequences.
E) Referral to a family therapist before making any formal reports.
Correct Answer: C) interview the teen w/o the parents; call CPS
Rationale: Safety and objective assessment are the priorities when abuse is suspected. An
adolescent may feel intimidated or coerced if interviewed in the presence of potential
perpetrators (the parents). To obtain an accurate and untainted history, the PMHNP must
separate the teen from the parents. Once a claim of abuse is made by a minor, the PMHNP
is a mandatory reporter and must notify Child Protective Services (CPS) regardless of
personal opinion on the validity of the claim.
Question 2
Which three primary neurotransmitters are most significantly associated with the
pathophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD)?
A) Dopamine, Acetylcholine, and GABA
B) Norepinephrine, Glutamate, and Serotonin
C) Dopamine, Norepinephrine, and Serotonin (5HT)
D) Serotonin, GABA, and Oxytocin
E) Epinephrine, Histamine, and Dopamine
Correct Answer: C) DA, NE, 5HT aka serotonin
Rationale: ADHD is largely understood as a disorder of neurotransmitter dysregulation in
the brain’s executive centers. Dopamine (DA) is linked to reward, motivation, and physical
movement; Norepinephrine (NE) is critical for sustained attention and alertness; and
Serotonin (5HT) plays a role in behavioral inhibition and impulse control. Medications for
ADHD, particularly stimulants and certain non-stimulants, target these systems to improve
focus and reduce impulsivity.
Question 3
In the neurobiology of ADHD, which of the following sets of brain structures are most
commonly associated with the symptoms of the disorder?
A) Occipital lobe, Thalamus, and Amygdala
B) Frontal cortex, Basal ganglia, and Reticular Activating System
, 2
C) Cerebellum, Hippocampus, and Temporal lobe
D) Hypothalamus, Medulla oblongata, and Parietal lobe
E) Corpus callosum, Pineal gland, and Pons
Correct Answer: B) Frontal cortex, Basal ganglia, Reticular Activating System
Rationale: The Frontal Cortex manages executive functions (planning, impulse control). The
Basal Ganglia are involved in motor control and the "filtering" of information. The
Reticular Activating System (RAS) is responsible for arousal and consciousness, serving as
a gateway for sensory input. Dysfunction in the connectivity between these three regions
leads to the hallmark ADHD symptoms of inattention, hyperactivity, and impulsivity.
Question 4
A 10-year-old child is diagnosed specifically with ADHD, Inattentive Type. According to
neuroimaging studies and pathophysiological models, which specific area of the brain most
likely demonstrates abnormalities in this type?
A) Occipital cortex
B) Prefrontal cortex
C) Basal ganglia
D) Limbic system
E) Parietal lobe
Correct Answer: B) Prefrontal cortex
Rationale: The Prefrontal Cortex (PFC) is the seat of executive functioning, including the
ability to sustain attention, inhibit distracting stimuli, and organize thoughts. While the
Basal Ganglia are more linked to the hyperactive/motor components of ADHD, the
"Inattentive Type" is primarily associated with decreased activation or structural
abnormalities within the Prefrontal Cortex.
Question 5
What is the absolute priority assessment that must be completed before a PMHNP places a
pediatric or adult patient on a stimulant medication for ADHD?
A) Liver function tests (LFTs)
B) Comprehensive cardiac history and physical
C) Fasting blood glucose levels
D) Thyroid stimulating hormone (TSH) level
E) Assessing for a history of gluten intolerance
Correct Answer: B) Cardiac history
Rationale: Stimulants are sympathomimetic drugs that can increase heart rate and blood
pressure. While they are generally safe, they pose a risk to patients with undiagnosed
structural heart abnormalities, arrhythmias, or other cardiac issues. A thorough cardiac
history (including family history of sudden cardiac death) and a physical exam are
, 3
mandatory to ensure the patient can safely tolerate the stimulant's effects on the
cardiovascular system.
Question 6
A 28-year-old patient reports "excessive worry and apprehension" regarding their job, health, and
finances. They state this worry has occurred "more days than not" for the last 7 months. Which
diagnosis is most consistent with this presentation?
A) Social Anxiety Disorder
B) Panic Disorder
C) Generalized Anxiety Disorder (GAD)
D) Acute Stress Disorder
E) Obsessive-Compulsive Disorder (OCD)
Correct Answer: C) GAD
Rationale: The DSM-5 criteria for Generalized Anxiety Disorder (GAD) require excessive
anxiety and worry occurring more days than not for a period of at least 6 months about a
number of events or activities. The patient's presentation of 7 months of persistent worry
across multiple domains (job, health, finances) fits this diagnostic timeframe and pattern.
Question 7
A child presents with both ADHD and a co-occurring motor tic disorder. Which class of ADHD
medications is generally considered contraindicated or should be used with extreme caution in
this scenario?
A) Alpha-2 agonists
B) Selective Norepinephrine Reuptake Inhibitors (SNRIs)
C) Stimulants
D) Selective Serotonin Reuptake Inhibitors (SSRIs)
E) Typical Antipsychotics
Correct Answer: C) Stimulants
Rationale: Stimulants increase dopamine levels, which can potentially exacerbate motor or
vocal tics in susceptible individuals. While some recent research suggests stimulants may
not always worsen tics, traditional board exams and clinical guidelines often flag stimulants
as contraindicated or requiring extreme caution when a tic disorder is present. Non-
stimulants like Guanfacine are often preferred in these cases.
Question 8
A patient on a stimulant for ADHD reports that the medication "helped for a few hours, but then
the focus disappeared by lunch." The PMHNP determines the medication provides some but not
enough benefit. In pharmacokinetics, what is the most likely explanation?
A) The patient is not taking the medication correctly.
B) The medication has been cleared from the body too quickly.
, 4
C) The patient has developed an immediate tolerance.
D) The dose is too high, causing a paradoxical effect.
E) The patient has a co-occurring personality disorder.
Correct Answer: B) the medication has been cleared from the body
Rationale: If a patient experiences a therapeutic benefit that is short-lived or "wears off"
too quickly, it indicates that the drug’s concentration in the blood has dropped below the
therapeutic window. This is common with short-acting stimulants. The PMHNP may need
to consider a long-acting (extended-release) formulation or a second dose later in the day to
maintain coverage.
Question 9
What is the FDA-approved lower age limit for the use of Amphetamine (AMPH) based
stimulants (e.g., Adderall) in children with ADHD?
A) 1 year old
B) 3 years old
C) 5 years old
D) 6 years old
E) 12 years old
Correct Answer: B) AMPH = 3yrs
Rationale: Amphetamine-based stimulants are approved by the FDA for children as young
as 3 years old. This is an important clinical distinction compared to methylphenidate-based
stimulants, which have a higher approved age limit. However, behavioral interventions are
still recommended as first-line for preschool-aged children.
Question 10
What is the FDA-approved lower age limit for the use of Methylphenidate (MPH) based
stimulants (e.g., Ritalin) in children with ADHD?
A) 3 years old
B) 4 years old
C) 5 years old
D) 6 years old
E) 18 years old
Correct Answer: D) MPH = 6yrs
Rationale: Unlike amphetamines, which are approved starting at age 3, Methylphenidate-
based products are generally approved by the FDA for children starting at 6 years of age.
Understanding these age limits is crucial for safe and legal prescribing in pediatric
populations.
